Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$35.76
+4.8%		$41.40
$18.08
▼
$51.60
$1.99B0.87556,120 shs909,931 shs
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$43.35
+9.8%		$40.84
$19.30
▼
$47.02
$2.16B0.1390,493 shs1.05 million shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$16.57
+6.5%		$13.28
$5.63
▼
$16.60
$2.13B1.742.34 million shs1.35 million shs
SRTA
Strata Critical Medical
$5.79
+3.6%		$5.47
$3.68
▼
$6.50
$501.01M2.25983,404 shs1.31 million shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrana Health, Inc. stock logo
ASTH
Astrana Health
-4.74%-6.95%-27.44%-13.16%+56.49%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
-2.80%-4.51%-1.11%+9.25%+88.25%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-1.08%-2.02%+7.31%+73.66%+183.42%
SRTA
Strata Critical Medical
-4.44%+9.82%+6.68%+0.36%+558,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$35.76
+4.8%		$41.40
$18.08
▼
$51.60
$1.99B0.87556,120 shs909,931 shs
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$43.35
+9.8%		$40.84
$19.30
▼
$47.02
$2.16B0.1390,493 shs1.05 million shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$16.57
+6.5%		$13.28
$5.63
▼
$16.60
$2.13B1.742.34 million shs1.35 million shs
SRTA
Strata Critical Medical
$5.79
+3.6%		$5.47
$3.68
▼
$6.50
$501.01M2.25983,404 shs1.31 million shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astrana Health, Inc. stock logo
ASTH
Astrana Health
-4.74%-6.95%-27.44%-13.16%+56.49%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
-2.80%-4.51%-1.11%+9.25%+88.25%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-1.08%-2.02%+7.31%+73.66%+183.42%
SRTA
Strata Critical Medical
-4.44%+9.82%+6.68%+0.36%+558,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astrana Health, Inc. stock logo
ASTH
Astrana Health
2.78
Moderate Buy$48.2935.03% Upside
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
2.78
Moderate Buy$43.831.11% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.73
Moderate Buy$16.710.87% Upside
SRTA
Strata Critical Medical
2.75
Moderate Buy$8.0038.17% Upside

Current Analyst Ratings Breakdown

Latest SRTA, NEO, GRDN, and ASTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$43.00 ➝ $49.00
8/7/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$50.00 ➝ $53.00
8/6/2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/5/2026
SRTA
Strata Critical Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C) ➝ Hold (C-)
7/31/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$19.00
7/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
7/24/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$11.00 ➝ $16.00
7/15/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/14/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/14/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$45.00 ➝ $50.00
(Data available from 8/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$3.18B0.63$2.81 per share12.73$14.09 per share2.54
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$1.45B1.49$1.35 per share32.15$3.44 per share12.60
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$766.30M2.78$0.35 per share46.95$6.12 per share2.71
SRTA
Strata Critical Medical
$197.14M2.54N/AN/A$3.23 per share1.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$22.49M$0.6158.6219.33N/A0.86%9.22%3.54%N/A
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$49.22M$0.8352.2334.682.733.64%30.72%15.99%N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$108.03M-$0.40N/A414.25N/A-6.77%-1.99%-1.21%N/A
SRTA
Strata Critical Medical
$41.35M-$0.08N/AN/AN/A15.71%-2.97%-2.54%N/A

Latest SRTA, NEO, GRDN, and ASTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
$0.2617$0.29+$0.0283$0.34$340.45 million$351.77 million
7/28/2026Q2 2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$0.0336$0.05+$0.0165$0.02$196.93 million$201.66 million
5/7/2026Q1 2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$0.29$0.74+$0.45$0.29$949.21 million$965.10 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Astrana Health, Inc. stock logo
ASTH
Astrana Health
N/AN/AN/AN/AN/A
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
SRTA
Strata Critical Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astrana Health, Inc. stock logo
ASTH
Astrana Health
1.20
1.35
1.35
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/A
1.46
1.17
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.48
3.60
3.35
SRTA
Strata Critical Medical
N/A
2.64
5.93

Institutional Ownership

CompanyInstitutional Ownership
Astrana Health, Inc. stock logo
ASTH
Astrana Health
52.77%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
SRTA
Strata Critical Medical
47.36%

Insider Ownership

CompanyInsider Ownership
Astrana Health, Inc. stock logo
ASTH
Astrana Health
20.30%
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
32.96%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
1.10%
SRTA
Strata Critical Medical
15.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Astrana Health, Inc. stock logo
ASTH
Astrana Health
3,00055.72 million44.41 millionOptionable
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
3,60049.78 million33.37 millionN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,500128.48 million127.06 millionOptionable
SRTA
Strata Critical Medical
13086.53 million73.12 millionN/A

Recent News About These Companies

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
August 6 at 1:21 PM  |  zacks.comhttps://www.zacks.com/stock/news/2970255/can-strata-critical-medical-inc-srta-run-higher-on-rising-earnings-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_8-2970255
Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation
August 5 at 11:40 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4930895-strata-critical-medical-inc-2026-q2-results-earnings-call-presentation
财报电话会议纪要：Strata Critical Medical第二季度营收超预期
August 5 at 9:23 AM  |  cn.investing.comhttps://cn.investing.com/news/transcripts/article-93CH-3496437
Strata Critical Medical overtreft Q2 2026 omzetverwachting
August 5 at 9:23 AM  |  nl.investing.comhttps://nl.investing.com/news/transcripts/strata-critical-medical-overtreft-q2-2026-omzetverwachting-93CH-875090
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Strata Critical Medical (SRTA)
August 5 at 9:23 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SRTA/pressreleases/3637732/analysts-offer-insights-on-healthcare-companies-siemens-healthineers-ag-othersemhf-and-strata-critical-medical-srta/
Strata Critical Medical Q2 Call Signals Clinical Upswing
August 4 at 9:11 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/strata-critical-medical-q2-call-signals-clinical-upswing?utm_source=marketbeat.com&utm_medium=referral
Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
August 4 at 11:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4929886-strata-critical-medical-inc-srta-q2-2026-earnings-call-transcript
Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know
August 4 at 10:56 AM  |  zacks.comhttps://www.zacks.com/stock/news/2967549/wall-street-analysts-predict-a-60-upside-in-strata-critical-medical-inc-srta-here-s-what-you-should-know?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2967549
Strata Critical Medical (NASDAQ:SRTA) Issues Earnings Results
August 4 at 10:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/strata-critical-medical-nasdaqsrta-issues-earnings-results-2026-08-04/
Strata Critical Medical Q2 Revenue Rises 60.7% to $72.5 Million
August 4 at 7:31 AM  |  quiverquant.comQ
Strata Critical Medical Announces Second Quarter 2026 Results
August 4 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338160/0/en/strata-critical-medical-announces-second-quarter-2026-results.html
Blade Air Mobility Q2 earnings preview
August 4 at 1:25 AM  |  msn.comhttps://www.msn.com/en-us/money/general/blade-air-mobility-q2-earnings-preview/ar-AA29jHgN
Strata Critical Medical to Report Second Quarter 2026 Financial Results on August 4, 2026
July 21, 2026  |  quiverquant.comQ
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330956/0/en/strata-critical-medical-schedules-second-quarter-2026-earnings-conference-call.html
Strata Critical Medical (NASDAQ:SRTA) Short Interest Down 47.9% in June
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/strata-critical-medical-nasdaqsrta-short-interest-down-479-in-june-2026-07-15/
Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics
July 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4920262-strata-critical-medical-a-better-alternative-to-transmedics-in-organ-transplant-logistics?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Strata Critical Medical Inc. - Ordinary Shares - Class A
June 27, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/srta-strata-critical-medical-inc-ordinary-shares-class-a
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
June 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/24/3316888/0/en/strata-acquires-heart-and-lung-transplant-national-recovery-program-expanding-national-organ-recovery-platform.html
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
June 16, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2937765/strata-critical-medical-inc-srta-surges-8-5-is-this-an-indication-of-further-gains?cid=cs-stocknewsapi-ft-tale_of_the_tape|daily_price_change_5%-2937765
Insider Selling: Strata Critical Medical (NASDAQ:SRTA) CAO Sells 4,655 Shares of Stock
June 11, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-srta-insider-buying-and-selling-2026-06-11/
Strata Critical Medical Insiders Make Bold Moves With Major Stock Sales
June 10, 2026  |  tipranks.comhttps://www.tipranks.com/news/insider-trading/strata-critical-medical-insiders-make-bold-moves-with-major-stock-sales-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Illuminated IREN logo stands amid rows of data center buildings and electrical infrastructure at sunset in a desert setting.
IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story
By Jeffrey Neal Johnson | July 21, 2026
Nebius logo displayed in a data center aisle lined with illuminated blue server racks.
Blueprint for a Billion: Nebius Group Secures the AI Floor
By Jeffrey Neal Johnson | July 15, 2026
A SpaceX rocket stands on a launch tower at dusk near an illuminated satellite ground station facility.
A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
By Jeffrey Neal Johnson | July 20, 2026
Nebius logo on a computer chip surrounded by glowing green circuit lines on a circuit board.
Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
By Jeffrey Neal Johnson | July 23, 2026
Astrana Health stock logo

Astrana Health NASDAQ:ASTH

$35.76 +1.63 (+4.78%)
Closing price 04:00 PM Eastern
Extended Trading
$35.05 -0.71 (-1.98%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Guardian Pharmacy Services stock logo

Guardian Pharmacy Services NYSE:GRDN

$43.35 +3.88 (+9.83%)
Closing price 03:59 PM Eastern
Extended Trading
$43.81 +0.46 (+1.06%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

NeoGenomics stock logo

NeoGenomics NASDAQ:NEO

$16.57 +1.01 (+6.49%)
Closing price 04:00 PM Eastern
Extended Trading
$16.29 -0.28 (-1.69%)
As of 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Strata Critical Medical NASDAQ:SRTA

$5.79 +0.20 (+3.58%)
Closing price 04:00 PM Eastern
Extended Trading
$5.82 +0.03 (+0.52%)
As of 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas